Hit & Target ID/Validation, Presentations, Structural Biology & Protein Science Thermostability assays in drug discovery: Evotec workflows and future perspectives 24 November 2022 Learn more
Articles & Whitepapers, Hit & Target ID/Validation, In vitro Biology, Neuroscience Combined treatment with a selective PDE10A inhibitor TAK-063 and either haloperidol or olanzapine at subeffective doses produces potent antipsychotic-like effects 27 June 2022 Learn more
Hit & Target ID/Validation, In vitro Biology, Neuroscience, Posters High Density Multi Electrode Array: a new tool to monitor seizure-like activity evoked by different convulsant drugs 27 June 2022 Learn more
Hit & Target ID/Validation, In vitro Biology, Neuroscience, Posters Purkinje cells firing recorded by a high density multi-electrode array: a new tool for compounds validation 27 June 2022 Learn more
Blog, Hit & Target ID/Validation, In vitro Biology, In vivo Pharmacology, IND Enabling Studies/Preclinical Development, Oncology, Videos & Webinars RNA-Based Medicine: Expanding the Druggable Target Space to RNA 29 March 2022 Learn more
Anti-Infectives, Articles & Whitepapers, Hit & Target ID/Validation Identification of β-Lactams Active Against Mycobacterium Tuberculosis 10 March 2022 Learn more
Anti-Infectives, Fact Sheets, Hit & Target ID/Validation BSL3 High Throughput Screening Capabilities Fact Sheet 8 March 2022 Learn more
Articles & Whitepapers, Hit & Target ID/Validation User Friendly Quantum Mechanics and Applications in Drug Discovery 26 November 2021 Learn more
Articles & Whitepapers, Hit & Target ID/Validation Real Life Drug Design Cases using AI, Machine Learning, and Deep Learning 26 November 2021 Learn more
Articles & Whitepapers, Hit & Target ID/Validation Computational Chemistry and Deep Learning 26 November 2021 Learn more
Anti-Infectives, Articles & Whitepapers, Hit & Target ID/Validation The Fight against COVID-19 with Artificial Intelligence 26 November 2021 Learn more
Articles & Whitepapers, Hit & Target ID/Validation Deep Learning Applied to Ligand-Based De Novo Drug Design 11 November 2021 Learn more
